blog

Tips from March Madness: Promoting Clinical Trial Product Awareness

By Michael Johnson on Thu, Mar 23, 2017 | 3 min read

It’s the greatest time of the year, well at least in my opinion. It’s March Madness. For those of you who don’t know, every year in March the NCAA basketball tournament captures the eye of the sporting world, consisting of brackets, upsets, buzzer beaters, and heartbreak.

Where am I going with this? As I sit in my office, I think about some of the biggest issues that face the clinical trial industry regarding the adoption and implementation of new products.

Topics: clinical research, clinical trials

Roche/BBK Worldwide Webinar on the Power of mHealth Replay Now Available

By BBK on Fri, Nov 4, 2016 | 3 min read

During last week’s webinar with BBK President Matt Kibby and Roche’s Operational Intelligence Leader, Lewis Millen, on “Harnessing the Power of mHealth for New, Better Data and Improved Patient Engagement,” we had the opportunity to cover a variety of topics and challenges related to mHealth adoption and deployment. And we were pleased to have so many representatives from all areas of clinical R&D, including patients, join us. Lewis was able to provide such valuable insights and if you joined us, you know that first hand.

Topics: mHealth, Webinars, Patient Engagement, big data, clinical trials, clinical research

Patient-centric Informed Consent: Weighing in on Product and Process

By Bonnie A. Brescia on Tue, Sep 20, 2016 | 5 min read

About this time each year I blog about how much I hate cancer. This year, it’s a bit tougher as my father was diagnosed with advanced head and neck cancer in June. Once again I am reminded about the difference it makes to be knowledgeable about clinical trials when making treatment decisions. We ask more questions. We explore more options. We filter what we hear through experience. And, we know when the informed consent process isn’t being done well – or even in compliance with regulations.

Topics: clinical trials, clinical research, informed consent, Patient Centricity

New eBook: Industry Insights on Rare Disease Research

By BBK on Tue, Apr 12, 2016 | 1 min read



Our “Focus 5” eBook series, in which we share the insights of five thought leaders on a variety of industry topics and trends, has been incredibly well-received, and we’re pleased to issue the latest installment in the series on Rare Disease Research. Patient advocates, researchers and physicians from NORD, Xenon Pharmaceuticals, Landon Pediatric Foundation, Rare Genomics Institute and RareShare.org all weigh in on where we are today and what we can do to help advance research.

Topics: Patient Centricity, Rare Disease, clinical trials, Rare Disease Research

Thoughts from Rare Disease Day: Moving Forward and Raising the Patient Voice

By David Kerner on Thu, Mar 17, 2016 | 2 min read

A few weeks ago, we attended NORD’s 7th Annual Rare Disease Day in Boston. People impacted by rare diseases, including patients and patient advocates, industry thought leaders and legislators, gathered at the State House to help raise awareness of the impact rare diseases have on the lives of millions of people in the US and around the world.

Topics: Patient Centricity, Rare Disease, clinical trials

Part II: Top Trends Paving the Way for Clinical Trial Success

By BBKWorldwide on Thu, Sep 3, 2015 | 3 min read

In last week’s post I focused on how socio-techno advancements, a balanced patient outreach plan, and optimal outreach strategies work to enhance patient recruitment and engagement. While those three trends are painting a picture for how to optimize the clinical trial practices of the future, there are two more top trends that will help to round out any campaign.

Topics: Patient Engagement, clinical trials

Top Trends Paving the Way for Clinical Trial Success

By BBKWorldwide on Thu, Aug 27, 2015 | 4 min read

We recently posted about the consumerization of health care that is truly driving change. Today I’d like to look at a few trends to keep an eye on that will prepare us for clinical trial success in the coming years.

Topics: clinical trials

The Pros & Cons of Social Media for Clinical Trials

By Sarah Mandracchia on Thu, Jul 9, 2015 | 2 min read

We all know that social media has the power to reach the masses in record speed. According to Quorum Review IRB, which recently led a webinar on embracing social media for clinical trials, there are more than one billion users on Facebook and 500 million users on Twitter. Within clinical research, social media can be an easy way to connect with the patient population. It offers the chance to get personal with like-minded people who are open and willing to share their journey regarding a specific diagnosis or indication.

Topics: Social Media, clinical trials

Streaming Video Clicks with Healthcare Consumers

By Justin Jones on Tue, May 5, 2015 | 3 min read

We all know that GoogleTM is the biggest search engine in the world. Did you know that YouTubeTM is number two, with over three billion searches each month? With streaming video expected to make up approximately 70 percent of all Internet traffic by 2018, now is the time to capitalize on integrating it into your clinical trial recruitment strategy.

Topics: advertising, clinical trials

 
Subscribe To Our Blog